Violation Tracker Individual Record

Company: 
Novo Nordisk Inc.
Current Parent Company: 
Novo Holdings A/S
Penalty: 
$1,725,000
Year: 
2011
Date: 
June 10, 2011
Offense Group: 
government-contracting-related offenses
Primary Offense: 
False Claims Act and related
Violation Description: 

Novo Nordisk, Inc. entered into a civil settlement agreement in which it has agreed to pay the United States and several states $1.725 million to resolve allegations that the company caused false or fraudulent claims to be submitted to the Medicaid program in connection with its marketing of the diabetes drugs Novolin, Novolin 70/30, Novolog, and Novolog 70/30.

Level of Government: 
federal
Action Type: 
agency action
Agency: 
U.S. Attorney-Eastern District of New York
Civil or Criminal Case: 
civil
HQ Country of Parent: 
Denmark
Ownership Structure of Parent: 
privately held
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.